Telix Pharmaceuticals (TLX) Equity Ratio (2023 - 2024)
Telix Pharmaceuticals has reported Equity Ratio over the past 2 years, most recently at 0.37 for Q4 2024.
- Quarterly Equity Ratio rose 2.15% to 0.37 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was 0.37 through Dec 2024, up 2.15% year-over-year, with the annual reading at 0.37 for FY2024, 2.15% up from the prior year.
- Equity Ratio was 0.37 for Q4 2024 at Telix Pharmaceuticals, up from 0.37 in the prior quarter.
- Over five years, Equity Ratio peaked at 0.37 in Q4 2024 and troughed at 0.37 in Q4 2023.